Visceral leishmaniasis is a chronic parasitic condition which is caused by infection with Leishmania donovani. It usually occurs in liver, spleen, lymph nodes and bone marrow. This condition presents with its characteristic clinical features. The gold standard of treatment includes the demonstration of amastigotes. Whereas, serological tests like ELISA, IFAT are used. Amongst the commonly used treatment strategies, Amp B and paromomycin are a few.

----------------------------------------
Infectious Medicine Lectures Collection -
[ Ссылка ]
----------------------------------------

LEISHMANIA DONOVANI DISEASE
Visceral leishmaniasis is caused by L. Donovani complex which includes L. Donovani and L. Infantum. Apart from epidemiology, immunopathogenesis has been explained here. Diseased individuals causes Mɸ alternative activation/dysfunction alongside PMN dysfunction which leads to persistent infection and tissue damage.

----------------------------------------
Lecture Duration - 00:46:43
Release Date - June 2019

Watch complete lecture on sqadia.com -
[ Ссылка ]
----------------------------------------

VISCERAL LEISHMANIASIS DIAGNOSIS
Individuals with visceral leishmaniasis demonstrate hepatomegaly, lymphadenopathy nad hypoalbuminemia. Gold standard of diagnosis includes demonstration of amastigotes in smears of tissue aspirates. Detection occurs via various serological tests which are ELISA and indirect immunofluorescent antibody tests (IFAT). Also, rapid immunochromatographic tests and PCR alongside diffferential diagnosis is described.

----------------------------------------
1400+ Medical Courses Lectures.
Try for FREE! - [ Ссылка ]
----------------------------------------

VISCERAL LEISHMANIASIS TREATMENT
Amongst the various available treatment options, pentavalent antimicrobial compounds forms a part of the treatment therapy. Moreover, amphotericin B along with liposomal AmB and paromomycin are also utilized to alleviate the condition. Besides, miltefosine is used. Moreover, multidrug therapy together with VL in immunocompromised hosts is explicated.

----------------------------------------
Facebook - [ Ссылка ]
Instagram - [ Ссылка ]
LinkedIN - [ Ссылка ]
Pinterest - [ Ссылка ]
TumblR - [ Ссылка ]
Twitter - [ Ссылка ]
Vimeo - [ Ссылка ]
YouTube - [ Ссылка ]
----------------------------------------

свернуть